News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Clearside Biomedical Names Charles Deignan Chief Financial Officer



10/29/2012 6:29:32 AM

ATLANTA--(BUSINESS WIRE)--Clearside Biomedical Inc., an ophthalmic pharmaceutical company developing and commercializing targeted therapeutics for the treatment of sight-threatening diseases, announced today that Charles Deignan has been named to the position of Chief Financial Officer. Deignan will report to Daniel White, President and CEO.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES